Navigation Links
Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial
Date:12/2/2009

innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the risk that that the results of future clinical studies will not correlate or be consistent with the results of the completed studies to date and the risk that the company will experience delays or difficulties in enrolling patients in any planned future clinical studies. Factors that could cause actual results to differ materially or otherwise adversely impact the company's ability to obtain regulatory approval for its product candidates include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are current
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
7. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... (PRWEB) March 31, 2015 Eastern ... schools for online bachelor’s of criminal justice degree ... connecting people to inspiring ideas and high quality ... e-mail to the University. We are confident that ... , This is the site’s first “Students ...
(Date:3/31/2015)... , March 31, 2015   Mapi ... integrating Mapi,s Medical Affairs and global Risk Management ... a previously announced acquisition . ... are conducted by a global team that includes ... have decades of experience in navigating complex safety ...
(Date:3/31/2015)... 31, 2015 Today, Cryos International, the ... of their U.S. facilities and inventory from New York ... of experience, Cryos’ relocation is a reflection of their ... to Orlando was completed during the first weekend of ... taking place on April 6. The new facility in ...
(Date:3/30/2015)... 2015  Multiple new research abstracts suggest walnuts may ... factors. From their impact on colon cancer and certain ... both gut health and vascular health, the research findings ... understanding of walnuts, inner workings. Running March 28 through ... annual meeting attracts an international audience of over 14,000 ...
Breaking Biology Technology:EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Cryos International Completes Groundbreaking Sperm Migration to Orlando, Florida 2New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4
... Jan. 8 InteKrin Therapeutics, Inc.,will present at the ... Pacific Time on Tuesday, January 13, 2009, to be ... InteKrin Therapeutics, President and,CEO Denny Lanfear will present at ... ( http://www.InteKrin.com ): , InteKrin ...
... Last 10 Years Helping Implement World Bank HIV/AIDS and ... that Dr. John Osika has joined the company as ... Dr. Osika, a board certified physician in the ... health expert with extensive experience working on HIV/AIDS and ...
... 8 Mindful of the tragedy of Sept. ... Edgewood Chemical Biological Center,s (ECBC) Environmental BioMonitoring Laboratory ... that address the new world demands for global ... control."We continue to work towards continuous expansion and ...
Cached Biology Technology:InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13 2Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 3
(Date:3/10/2015)... , March 10, 2015 ... "Personalized Medicine in Human Space Flight" ... Thomas J. Goodwin , Ph.D. was recently featured ... the past two years. Specifically, "Personalized Medicine ... downloaded scientific papers published in 2013 and 2014 from ...
(Date:3/5/2015)... -- In Brazil , cloud computing is ... solutions and 42 percent planning to invest in them by ... of the companies will be investing in these solutions for ... in the region are currently opting for the private cloud ... significant attention in the coming years. This trend is in ...
(Date:3/2/2015)... 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced a new implementation of its ... rapid and secure transactions and reliable identification for ... a turnkey solution providing mouse and keyboard peripheral ... fingerprint ID solutions into their product offerings, bringing ...
Breaking Biology News(10 mins):"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
... the hormone jasmonate works to protect plants and promote ... the jasmonate signaling pathway makes its way into the ... recently published discovery will eventually help farmers experience better ... "This is a small piece of a bigger picture, ...
... clinical trial, physician-researchers at University Hospitals (UH) Case ... use of "Lose It!," a free Smartphone application ... Lappen, MD, Assistant Director, Residency Program, Department of ... Hospital, is recruiting postpartum patients to measure the ...
... grass species may be one reason fires are bigger and ... according to a team of researchers. Researchers used satellite imagery ... in the west during the 1800s, in a disproportionately high ... arid area in the west that includes large sections of ...
Cached Biology News:Biologists unlocking the secrets of plant defenses, 1 piece at a time 2Invasive grass fuels increased fire activity in the West 2Invasive grass fuels increased fire activity in the West 3
...
... Fixed Angle Polypropylene Rotor designed for ... Centra CL3/CL3R** and Centra-MP4/MP4R*. A translucent ... /MP4, ,EXCLUSIVE polypropylene rotor design provides ... repeatedly autoclaved. Polypropylene rotors are ...
The 891 45° Fixed Angle Rotor is designed to provide aerosol containment and can be removed from a centrifuge (seal entact) and opened under an environmental hood....
... is a powerful technology platform that automates ... High quality sample preparation can be ... The Xcise is a powerful technology platform ... proteome analysis. It combines the functions of ...
Biology Products: